BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 30385267)

  • 21. Activity of physalins purified from Physalis angulata in in vitro and in vivo models of cutaneous leishmaniasis.
    Guimarães ET; Lima MS; Santos LA; Ribeiro IM; Tomassini TB; Ribeiro dos Santos R; dos Santos WL; Soares MB
    J Antimicrob Chemother; 2009 Jul; 64(1):84-7. PubMed ID: 19454526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antileishmanial activity of a naphthoquinone derivate against promastigote and amastigote stages of Leishmania infantum and Leishmania amazonensis and its mechanism of action against L. amazonensis species.
    Mendonça DVC; Lage DP; Calixto SL; Ottoni FM; Tavares GSV; Ludolf F; Chávez-Fumagalli MA; Schneider MS; Duarte MC; Tavares CAP; Alves RJ; Coimbra ES; Coelho EAF
    Parasitol Res; 2018 Feb; 117(2):391-403. PubMed ID: 29248978
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Santos CC; Zhang H; Batista MM; de Oliveira GM; Demarque KC; da Silva-Gomes NL; Moreira OC; Ogungbe IV; Soeiro MNC
    Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 32928731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell death in amastigote forms of Leishmania amazonensis induced by parthenolide.
    Tiuman TS; Ueda-Nakamura T; Alonso A; Nakamura CV
    BMC Microbiol; 2014 Jun; 14():152. PubMed ID: 24913205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of nanoemulsions prepared with essential oils of copaiba- and andiroba against Leishmania infantum and Leishmania amazonensis infections.
    Dhorm Pimentel de Moraes AR; Tavares GD; Soares Rocha FJ; de Paula E; Giorgio S
    Exp Parasitol; 2018 Apr; 187():12-21. PubMed ID: 29518448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species.
    Nieto-Meneses R; Castillo R; Hernández-Campos A; Maldonado-Rangel A; Matius-Ruiz JB; Trejo-Soto PJ; Nogueda-Torres B; Dea-Ayuela MA; Bolás-Fernández F; Méndez-Cuesta C; Yépez-Mulia L
    Exp Parasitol; 2018 Jan; 184():82-89. PubMed ID: 29191699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of a Binuclear Cyclopalladated Compound Therapy for Cutaneous Leishmaniasis in the Murine Model of Infection with Leishmania amazonensis and Its Inhibitory Effect on Topoisomerase 1B.
    Velásquez AMA; Ribeiro WC; Venn V; Castelli S; Camargo MS; de Assis RP; de Souza RA; Ribeiro AR; Passalacqua TG; da Rosa JA; Baviera AM; Mauro AE; Desideri A; Almeida-Amaral EE; Graminha MAS
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28507113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leishmania amazonensis: effects of oral treatment with copaiba oil in mice.
    dos Santos AO; Costa MA; Ueda-Nakamura T; Dias-Filho BP; da Veiga-Júnior VF; de Souza Lima MM; Nakamura CV
    Exp Parasitol; 2011 Oct; 129(2):145-51. PubMed ID: 21771592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective effects of Euterpe oleracea (açai) on Leishmania (Leishmania) amazonensis and Leishmania infantum.
    Da Silva BJM; Souza-Monteiro JR; Rogez H; Crespo-López ME; Do Nascimento JLM; Silva EO
    Biomed Pharmacother; 2018 Jan; 97():1613-1621. PubMed ID: 29793323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bovine serum albumin nanoparticles containing amphotericin B were effective in treating murine cutaneous leishmaniasis and reduced the drug toxicity.
    Casa DM; Scariot DB; Khalil NM; Nakamura CV; Mainardes RM
    Exp Parasitol; 2018 Sep; 192():12-18. PubMed ID: 30026113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In Vitro and In Vivo Antileishmanial Activity of Thioridazine.
    Sifontes-Rodríguez S; Mollineda-Diogo N; Monzote-Fidalgo L; Escalona-Montaño AR; Escario García-Trevijano JA; Aguirre-García MM; Meneses-Marcel A
    Acta Parasitol; 2024 Mar; 69(1):324-331. PubMed ID: 38070122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel functionalized 1,2,3-triazole derivatives exhibit antileishmanial activity, increase in total and mitochondrial-ROS and depolarization of mitochondrial membrane potential of Leishmania amazonensis.
    Meinel RS; Almeida ADC; Stroppa PHF; Glanzmann N; Coimbra ES; da Silva AD
    Chem Biol Interact; 2020 Jan; 315():108850. PubMed ID: 31634447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antileishmanial activity and cytotoxicity of Brazilian plants.
    Ribeiro TG; Chávez-Fumagalli MA; Valadares DG; Franca JR; Lage PS; Duarte MC; Andrade PH; Martins VT; Costa LE; Arruda AL; Faraco AA; Coelho EA; Castilho RO
    Exp Parasitol; 2014 Aug; 143():60-8. PubMed ID: 24846006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Pluronic® F127-based polymeric micelle system containing an antileishmanial molecule is immunotherapeutic and effective in the treatment against Leishmania amazonensis infection.
    Tavares GSV; Mendonça DVC; Miyazaki CK; Lage DP; Soyer TG; Carvalho LM; Ottoni FM; Dias DS; Ribeiro PAF; Antinarelli LMR; Ludolf F; Duarte MC; Coimbra ES; Chávez-Fumagalli MA; Roatt BM; Menezes-Souza D; Barichello JM; Alves RJ; Coelho EAF
    Parasitol Int; 2019 Feb; 68(1):63-72. PubMed ID: 30339837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of Paromomycin-Chloroquine Combination Therapy in Experimental Cutaneous Leishmaniasis.
    Wijnant GJ; Van Bocxlaer K; Yardley V; Murdan S; Croft SL
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28607026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemical Characterization, Antileishmanial Activity, and Cytotoxicity Effects of the Essential Oil from Leaves of Pluchea carolinensis (Jacq.) G. Don. (Asteraceae).
    García M; Scull R; Satyal P; Setzer WN; Monzote L
    Phytother Res; 2017 Sep; 31(9):1419-1426. PubMed ID: 28703380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo activity of a palladacycle complex on Leishmania (Leishmania) amazonensis.
    Paladi Cde S; Pimentel IA; Katz S; Cunha RL; Judice WA; Caires AC; Barbiéri CL
    PLoS Negl Trop Dis; 2012; 6(5):e1626. PubMed ID: 22616018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and in vivo antileishmanial activity of 2-amino-4,6-dimethylpyridine derivatives against Leishmania mexicana.
    Abdala H; Alvarez N; Delmas F; Di Giorgio C; Robert JM; Le Baut G; Le Pape P
    Parasite; 2002 Dec; 9(4):367-70. PubMed ID: 12514953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epoxy-α-lapachone has in vitro and in vivo anti-leishmania (Leishmania) amazonensis effects and inhibits serine proteinase activity in this parasite.
    Souza-Silva F; Bourguignon SC; Pereira BA; Côrtes LM; de Oliveira LF; Henriques-Pons A; Finkelstein LC; Ferreira VF; Carneiro PF; de Pinho RT; Caffarena ER; Alves CR
    Antimicrob Agents Chemother; 2015 Apr; 59(4):1910-8. PubMed ID: 25583728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activities of ER-119884 and E5700, two potent squalene synthase inhibitors, against Leishmania amazonensis: antiproliferative, biochemical, and ultrastructural effects.
    Fernandes Rodrigues JC; Concepcion JL; Rodrigues C; Caldera A; Urbina JA; de Souza W
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4098-114. PubMed ID: 18765694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.